Role of complexin 2 in the regulation of hormone secretion from the islet of Langerhans

Regulated secretion of insulin from β-cells, glucagon from α-cells, and somatostatin from δ-cells is necessary for the maintenance of glucose homeostasis. The release of these hormones from pancreatic islets requires the assembly and disassembly of the SNARE protein complex to control vesicle fusion. Complexin 2 (Cplx 2) is a small soluble synaptic protein that participates in the priming and release of vesicles. It plays a dual role as a molecular switch that clamps and prevents fusion pore opening, which subsequently undergoes a conformational change upon Ca<sup>2+</sup> binding to synaptotagmin to facilitate exocytosis. Using a Cplx 2 knockout (KO) mouse model, we show a direct inhibitory role of Cplx 2 for glucagon and somatostatin secretion, along with an indirect role in the paracrine inhibition of insulin secretion by somatostatin. Deletion of Cplx 2 increases glucagon and somatostatin secretion from intact mouse islets, whereas there is no effect on insulin secretion. The normal paracrine inhibition of insulin secretion by somatostatin is disrupted in Cplx 2 KO islets. On the contrary, deletion of Cplx 2 did not affect the paracrine inhibition of glucagon by somatostatin at elevated glucose levels. In both β- and α-cells, the secretion profiles are parallel to Ca<sup>2+</sup> activity changes following somatostatin treatment of wild-type (WT) and Cplx 2 KO islets. The loss of paracrine inhibition of insulin secretion is substantiated by direct measurements of insulin vesicle fusion events in Cplx 2 KO islets. Together, these data show a differential role for Cplx 2 in regulating hormone secretion from pancreatic islets.<b>NEW & NOTEWORTHY</b> Complexin 2 (Cplx 2) is a small synaptic protein that functions to clamp and release the SNARE protein complex during exocytosis. We show that Cplx 2 has a direct inhibitory role in glucagon and somatostatin secretion from intact mouse islets. Furthermore, the deletion of Cplx 2 leads to disrupted inhibition of β-cell Ca<sup>2+</sup> activity and insulin secretion by somatostatin. These findings highlight a differential regulatory role of Cplx 2 in hormone secretion from pancreatic islets.

Authors

Institutions

Publication Details

Journal
American Journal of Physiology-Endocrinology and Metabolism
Published
2025-11-10
DOI
https://doi.org/10.1152/ajpendo.00519.2024
Primary Topic
Cellular transport and secretion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of complexin 2 in the regulation of hormone secretion from the islet of Langerhans

Xue Wen Ng, David W. Piston, Michael R. DiGruccio, Jeongmin Lee et al.
American Journal of Physiology-Endocrinology and Metabolism
Cellular transport and secretion
article

Role of complexin 2 in the regulation of hormone secretion from the islet of Langerhans

Xue Wen Ng, David W. Piston, Michael R. DiGruccio, Jeongmin Lee, Chen Kong
article en

Abstract

Regulated secretion of insulin from β-cells, glucagon from α-cells, and somatostatin from δ-cells is necessary for the maintenance of glucose homeostasis. The release of these hormones from pancreatic islets requires the assembly and disassembly of the SNARE protein complex to control vesicle fusion. Complexin 2 (Cplx 2) is a small soluble synaptic protein that participates in the priming and release of vesicles. It plays a dual role as a molecular switch that clamps and prevents fusion pore opening, which subsequently undergoes a conformational change upon Ca<sup>2+</sup> binding to synaptotagmin to facilitate exocytosis. Using a Cplx 2 knockout (KO) mouse model, we show a direct inhibitory role of Cplx 2 for glucagon and somatostatin secretion, along with an indirect role in the paracrine inhibition of insulin secretion by somatostatin. Deletion of Cplx 2 increases glucagon and somatostatin secretion from intact mouse islets, whereas there is no effect on insulin secretion. The normal paracrine inhibition of insulin secretion by somatostatin is disrupted in Cplx 2 KO islets. On the contrary, deletion of Cplx 2 did not affect the paracrine inhibition of glucagon by somatostatin at elevated glucose levels. In both β- and α-cells, the secretion profiles are parallel to Ca<sup>2+</sup> activity changes following somatostatin treatment of wild-type (WT) and Cplx 2 KO islets. The loss of paracrine inhibition of insulin secretion is substantiated by direct measurements of insulin vesicle fusion events in Cplx 2 KO islets. Together, these data show a differential role for Cplx 2 in regulating hormone secretion from pancreatic islets.<b>NEW & NOTEWORTHY</b> Complexin 2 (Cplx 2) is a small synaptic protein that functions to clamp and release the SNARE protein complex during exocytosis. We show that Cplx 2 has a direct inhibitory role in glucagon and somatostatin secretion from intact mouse islets. Furthermore, the deletion of Cplx 2 leads to disrupted inhibition of β-cell Ca<sup>2+</sup> activity and insulin secretion by somatostatin. These findings highlight a differential regulatory role of Cplx 2 in hormone secretion from pancreatic islets.

American Journal of Physiology-Endocrinology and MetabolismVol. 329(6)
Texas Tech University (US), Washington University in St. Louis (US), APT Therapeutics (United States) (US), Texas Tech University Health Sciences Center (US)
Openalex Percentile: Top 65%
Cellular transport and secretion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.